This study focuses on the RNA methyltransferase NSUN5, which not only possesses molecular diagnostic potential but may also contribute to glioma progression through modulation of the TME, thereby offering a novel target for precision therapy. The gene discussed is NSUN5; the disease is central nervous system cancer.